The infertility treatment market size has grown strongly in recent years. It will grow from $1.97 billion in 2025 to $2.15 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to delayed parenthood trends, increasing prevalence of lifestyle-related infertility, growing awareness of fertility treatments, expansion of ivf clinics, advancements in reproductive medicine.
The infertility treatment market size is expected to see strong growth in the next few years. It will grow to $3 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising infertility rates globally, increasing success rates of assisted reproductive technology, growing demand for fertility preservation, higher healthcare spending on reproductive health, expanding access to fertility treatments in emerging markets. Major trends in the forecast period include rising demand for assisted reproductive technologies, increasing acceptance of infertility treatments, growth in female and male fertility preservation, expansion of fertility clinics and specialized centers, advancements in hormonal and drug-based therapies.
The decline in the global fertility rate is a key factor driving the growth of the infertility treatment market. Fertility rate at a given age refers to the number of live births to women of that age during a year, expressed as a percentage of the average annual population of women of that age. Worldwide fertility rates are steadily decreasing due to factors such as the rising trend of delayed marriages and age-related infertility. This decline has led to increased demand for infertility treatment products that help determine the fertility window in both males and females. For example, in 2024, the United Nations Department of Economic and Social Affairs (UN DESA), a US-based international organization, estimated the global total fertility rate at 2.25 births per woman, projecting a decline to approximately 2.07 births per woman by 2054. Therefore, the declining fertility rate is boosting demand in the infertility treatment market.
Leading companies in the infertility treatment market are focusing on technological innovations, such as advanced motorized microscopy systems, to improve workflow efficiency and procedural precision in assisted reproductive treatments. Advanced motorized microscopy systems are automated optical microscopes with motor-driven controls that enhance imaging precision and efficiency, facilitating clearer visualization, accurate sperm selection, and smoother execution of delicate procedures with minimal manual intervention. For instance, in July 2024, Nikon Corporation, a Tokyo-based company, launched the ECLIPSE Ti2-I Motorized Inverted Microscope, specifically designed for micro-insemination procedures such as ICSI (Intracytoplasmic Sperm Injection) and IMSI (Intracytoplasmic Morphologically-Selected Sperm Injection). This innovative microscope improves workflow efficiency in reproductive medicine, making it easier for specialists to perform intricate infertility treatments.
In June 2024, CooperSurgical, a US-based company specializing in women’s health, acquired ZyMōt Fertility for an undisclosed amount. Through this acquisition, CooperSurgical expanded its fertility offerings by integrating ZyMōt’s advanced reproductive health technologies into its portfolio. ZyMōt Fertility is a US-based company engaged in developing innovative solutions to support reproductive health.
Major companies operating in the infertility treatment market are The Cooper Companies Inc., Cook Group Incorporated, Vitrolife AB, Thermo Fisher Scientific Inc., Esco Micro Pte. Ltd., Genea Limited, IVFtech ApS, FUJIFILM Irvine Scientific Inc., The Baker Company Inc., Kitazato Corporation, Rocket Medical PLC, IHMedical A/S, Hamilton Thorne Ltd., Carl Zeiss AG, MedGyn Products Inc., DxNow Inc., Nidacon International AB, Gynotec B.V., SAR Healthline Pvt. Ltd., InVitroCare Inc., Boston IVF, Shady Grove Fertility LLC, CCRM Fertility Co. LLC, IVI-RMA Global, Fertility Centers of Illinois, New Hope Fertility Center, Pacific Fertility Center, Houston Fertility Institute, Sher Fertility Institute, Columbia Asia Fertility Centre, Bourn Hall Fertility Clinic, Manipal Fertility, Morpheus IVF, Nova IVF Fertility, Indira IVF, Bloom Fertility Centre, Cloudnine Fertility, Oasis Fertility, Apollo Fertility, Milann Fertility Center, Fakih IVF, Procrea Fertility, The Montreal Fertility Center, The Center for Reproductive Medicine, The Reproductive Medicine Group, The Fertility Institute.
North America was the largest region in the infertility treatment market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the infertility treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infertility treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have affected the infertility treatment market by increasing the cost of imported ivf equipment, cryopreservation systems, and specialized consumables used in fertility procedures. These impacts are most visible in equipment- and media-intensive segments, particularly across asia-pacific and europe where reliance on cross-border sourcing is high. Increased tariffs have raised operational costs for hospitals and fertility clinics. However, tariffs are also encouraging domestic manufacturing of fertility equipment, local sourcing of consumables, and investments in cost-efficient technologies, supporting long-term market resilience.
The infertility treatment market research report is one of a series of new reports that provides infertility treatment market statistics, including infertility treatment industry global market size, regional shares, competitors with a infertility treatment market share, detailed infertility treatment market segments, market trends and opportunities, and any further data you may need to thrive in the infertility treatment industry. This infertility treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Infertility treatment involves addressing infertility in both males and females. Infertility is a condition of the male or female reproductive system characterized by the inability to achieve pregnancy after 12 months or more of regular, unprotected sexual intercourse. In females, infertility may result from conditions such as endometriosis, uterine fibroids, or thyroid disorders. In males, infertility may be caused by factors such as low testosterone levels or low sperm counts.
The main products used in infertility treatment include equipment, media and consumables, and accessories. Equipment is designed to treat infertility in both males and females and refers to instruments, apparatuses, implements, machines, appliances, implants, reagents for in vitro use, or materials intended by the manufacturer to be used alone or in combination for medical treatment purposes. Treatment procedures include assisted reproductive technologies, artificial insemination, fertility surgeries, and others, often involving drugs such as clomiphene citrate, letrozole, serophene, hormone therapies, and more. Infertility treatments are provided for both male and female patients and are used by end users such as hospitals and surgical clinics, cryobanks, and research institutes.
The infertility treatment market includes revenues earned by entities by providing fertility preservation, genetic carrier screening, egg treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The infertility treatment market size is expected to see strong growth in the next few years. It will grow to $3 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising infertility rates globally, increasing success rates of assisted reproductive technology, growing demand for fertility preservation, higher healthcare spending on reproductive health, expanding access to fertility treatments in emerging markets. Major trends in the forecast period include rising demand for assisted reproductive technologies, increasing acceptance of infertility treatments, growth in female and male fertility preservation, expansion of fertility clinics and specialized centers, advancements in hormonal and drug-based therapies.
The decline in the global fertility rate is a key factor driving the growth of the infertility treatment market. Fertility rate at a given age refers to the number of live births to women of that age during a year, expressed as a percentage of the average annual population of women of that age. Worldwide fertility rates are steadily decreasing due to factors such as the rising trend of delayed marriages and age-related infertility. This decline has led to increased demand for infertility treatment products that help determine the fertility window in both males and females. For example, in 2024, the United Nations Department of Economic and Social Affairs (UN DESA), a US-based international organization, estimated the global total fertility rate at 2.25 births per woman, projecting a decline to approximately 2.07 births per woman by 2054. Therefore, the declining fertility rate is boosting demand in the infertility treatment market.
Leading companies in the infertility treatment market are focusing on technological innovations, such as advanced motorized microscopy systems, to improve workflow efficiency and procedural precision in assisted reproductive treatments. Advanced motorized microscopy systems are automated optical microscopes with motor-driven controls that enhance imaging precision and efficiency, facilitating clearer visualization, accurate sperm selection, and smoother execution of delicate procedures with minimal manual intervention. For instance, in July 2024, Nikon Corporation, a Tokyo-based company, launched the ECLIPSE Ti2-I Motorized Inverted Microscope, specifically designed for micro-insemination procedures such as ICSI (Intracytoplasmic Sperm Injection) and IMSI (Intracytoplasmic Morphologically-Selected Sperm Injection). This innovative microscope improves workflow efficiency in reproductive medicine, making it easier for specialists to perform intricate infertility treatments.
In June 2024, CooperSurgical, a US-based company specializing in women’s health, acquired ZyMōt Fertility for an undisclosed amount. Through this acquisition, CooperSurgical expanded its fertility offerings by integrating ZyMōt’s advanced reproductive health technologies into its portfolio. ZyMōt Fertility is a US-based company engaged in developing innovative solutions to support reproductive health.
Major companies operating in the infertility treatment market are The Cooper Companies Inc., Cook Group Incorporated, Vitrolife AB, Thermo Fisher Scientific Inc., Esco Micro Pte. Ltd., Genea Limited, IVFtech ApS, FUJIFILM Irvine Scientific Inc., The Baker Company Inc., Kitazato Corporation, Rocket Medical PLC, IHMedical A/S, Hamilton Thorne Ltd., Carl Zeiss AG, MedGyn Products Inc., DxNow Inc., Nidacon International AB, Gynotec B.V., SAR Healthline Pvt. Ltd., InVitroCare Inc., Boston IVF, Shady Grove Fertility LLC, CCRM Fertility Co. LLC, IVI-RMA Global, Fertility Centers of Illinois, New Hope Fertility Center, Pacific Fertility Center, Houston Fertility Institute, Sher Fertility Institute, Columbia Asia Fertility Centre, Bourn Hall Fertility Clinic, Manipal Fertility, Morpheus IVF, Nova IVF Fertility, Indira IVF, Bloom Fertility Centre, Cloudnine Fertility, Oasis Fertility, Apollo Fertility, Milann Fertility Center, Fakih IVF, Procrea Fertility, The Montreal Fertility Center, The Center for Reproductive Medicine, The Reproductive Medicine Group, The Fertility Institute.
North America was the largest region in the infertility treatment market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the infertility treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infertility treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have affected the infertility treatment market by increasing the cost of imported ivf equipment, cryopreservation systems, and specialized consumables used in fertility procedures. These impacts are most visible in equipment- and media-intensive segments, particularly across asia-pacific and europe where reliance on cross-border sourcing is high. Increased tariffs have raised operational costs for hospitals and fertility clinics. However, tariffs are also encouraging domestic manufacturing of fertility equipment, local sourcing of consumables, and investments in cost-efficient technologies, supporting long-term market resilience.
The infertility treatment market research report is one of a series of new reports that provides infertility treatment market statistics, including infertility treatment industry global market size, regional shares, competitors with a infertility treatment market share, detailed infertility treatment market segments, market trends and opportunities, and any further data you may need to thrive in the infertility treatment industry. This infertility treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Infertility treatment involves addressing infertility in both males and females. Infertility is a condition of the male or female reproductive system characterized by the inability to achieve pregnancy after 12 months or more of regular, unprotected sexual intercourse. In females, infertility may result from conditions such as endometriosis, uterine fibroids, or thyroid disorders. In males, infertility may be caused by factors such as low testosterone levels or low sperm counts.
The main products used in infertility treatment include equipment, media and consumables, and accessories. Equipment is designed to treat infertility in both males and females and refers to instruments, apparatuses, implements, machines, appliances, implants, reagents for in vitro use, or materials intended by the manufacturer to be used alone or in combination for medical treatment purposes. Treatment procedures include assisted reproductive technologies, artificial insemination, fertility surgeries, and others, often involving drugs such as clomiphene citrate, letrozole, serophene, hormone therapies, and more. Infertility treatments are provided for both male and female patients and are used by end users such as hospitals and surgical clinics, cryobanks, and research institutes.
The infertility treatment market includes revenues earned by entities by providing fertility preservation, genetic carrier screening, egg treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Infertility Treatment Market Characteristics
3. Infertility Treatment Market Supply Chain Analysis
4. Global Infertility Treatment Market Trends and Strategies
5. Infertility Treatment Market Analysis of End Use Industries
7. Global Infertility Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Infertility Treatment Total Addressable Market (TAM) Analysis for the Market
9. Infertility Treatment Market Segmentation
10. Infertility Treatment Market Regional and Country Analysis
11. Asia-Pacific Infertility Treatment Market
12. China Infertility Treatment Market
13. India Infertility Treatment Market
14. Japan Infertility Treatment Market
15. Australia Infertility Treatment Market
16. Indonesia Infertility Treatment Market
17. South Korea Infertility Treatment Market
18. Taiwan Infertility Treatment Market
19. South East Asia Infertility Treatment Market
20. Western Europe Infertility Treatment Market
21. UK Infertility Treatment Market
22. Germany Infertility Treatment Market
23. France Infertility Treatment Market
24. Italy Infertility Treatment Market
25. Spain Infertility Treatment Market
26. Eastern Europe Infertility Treatment Market
27. Russia Infertility Treatment Market
28. North America Infertility Treatment Market
29. USA Infertility Treatment Market
30. Canada Infertility Treatment Market
31. South America Infertility Treatment Market
32. Brazil Infertility Treatment Market
33. Middle East Infertility Treatment Market
34. Africa Infertility Treatment Market
36. Infertility Treatment Market Competitive Landscape and Company Profiles
37. Infertility Treatment Market Other Major and Innovative Companies
40. Infertility Treatment Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Infertility Treatment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses infertility treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for infertility treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infertility treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Equipment; Media And Consumables; Accessories2) By Procedure: Assisted Reproductive Technology; Artificial Insemination; Fertility Surgeries; Other Infertility Treatment Procedures
3) By Drugs: Clomiphene Citrate; Letrozole; Serophene; Hormone Treatment; Other Drugs
4) By Patient Type: Female Infertility Treatment; Male Infertility Treatment
5) By End User: Hospitals And Surgical Clinics; Research Institutes
Subsegments:
1) By Equipment: In Vitro Fertilization (IVF) Equipment; Cryopreservation Equipment; Sperm And Embryo Storage Systems; Ultrasound Machines2) By Media And Consumables: Culture Media; Sperm Processing Media; Embryo Transfer Media; Oocyte Preservation Media
3) By Accessories: Catheters; Needles And Syringes; Petri Dishes; Incubators
Companies Mentioned: The Cooper Companies Inc.; Cook Group Incorporated; Vitrolife AB; Thermo Fisher Scientific Inc.; Esco Micro Pte. Ltd.; Genea Limited; IVFtech ApS; FUJIFILM Irvine Scientific Inc.; The Baker Company Inc.; Kitazato Corporation; Rocket Medical PLC; IHMedical A/S; Hamilton Thorne Ltd.; Carl Zeiss AG; MedGyn Products Inc.; DxNow Inc.; Nidacon International AB; Gynotec B.V.; SAR Healthline Pvt. Ltd.; InVitroCare Inc.; Boston IVF; Shady Grove Fertility LLC; CCRM Fertility Co. LLC; IVI-RMA Global; Fertility Centers of Illinois; New Hope Fertility Center; Pacific Fertility Center; Houston Fertility Institute; Sher Fertility Institute; Columbia Asia Fertility Centre; Bourn Hall Fertility Clinic; Manipal Fertility; Morpheus IVF; Nova IVF Fertility; Indira IVF; Bloom Fertility Centre; Cloudnine Fertility; Oasis Fertility; Apollo Fertility; Milann Fertility Center; Fakih IVF; Procrea Fertility; The Montreal Fertility Center; The Center for Reproductive Medicine; The Reproductive Medicine Group; The Fertility Institute
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Infertility Treatment market report include:- The Cooper Companies Inc.
- Cook Group Incorporated
- Vitrolife AB
- Thermo Fisher Scientific Inc.
- Esco Micro Pte. Ltd.
- Genea Limited
- IVFtech ApS
- FUJIFILM Irvine Scientific Inc.
- The Baker Company Inc.
- Kitazato Corporation
- Rocket Medical PLC
- IHMedical A/S
- Hamilton Thorne Ltd.
- Carl Zeiss AG
- MedGyn Products Inc.
- DxNow Inc.
- Nidacon International AB
- Gynotec B.V.
- SAR Healthline Pvt. Ltd.
- InVitroCare Inc.
- Boston IVF
- Shady Grove Fertility LLC
- CCRM Fertility Co. LLC
- IVI-RMA Global
- Fertility Centers of Illinois
- New Hope Fertility Center
- Pacific Fertility Center
- Houston Fertility Institute
- Sher Fertility Institute
- Columbia Asia Fertility Centre
- Bourn Hall Fertility Clinic
- Manipal Fertility
- Morpheus IVF
- Nova IVF Fertility
- Indira IVF
- Bloom Fertility Centre
- Cloudnine Fertility
- Oasis Fertility
- Apollo Fertility
- Milann Fertility Center
- Fakih IVF
- Procrea Fertility
- The Montreal Fertility Center
- The Center for Reproductive Medicine
- The Reproductive Medicine Group
- The Fertility Institute
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.15 Billion |
| Forecasted Market Value ( USD | $ 3 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 47 |
